(S)-3-ethylamino1-butanol | 136744-91-7

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: (S)-3-ethylamino1-butanol
• 英文别名: (S)-3-(ethylamino)butan-1-ol；(3S)-3-(ethylamino)butan-1-ol
• CAS: 136744-91-7
• 化学式: C₆H₁₅NO
• mdl: MFCD09864523
• 分子量: 117.191
• InChiKey: AXCSUIBUZBQBGT-LURJTMIESA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  8
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  32.3
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  methyl (Z)-3-acetamido-2-butenoate 在 lithium aluminium tetrahydride 、 bis(acetato){(R)-(+)-2,2'-bis(diphenylphosphino)-1,1'-binaphthyl}rutenium(II) 、 氢气 作用下， 以 四氢呋喃 、 甲醇 、 甲苯 为溶剂， 25.0 ℃ 、101.33 kPa 条件下， 反应 123.5h， 生成 (S)-3-ethylamino1-butanol
  参考文献：
  名称：

  Enantioselective synthesis of β-amino acids based on BINAP—ruthenium(II) catalyzed hydrogenation

  摘要：

  BINAP-Ru(II) catalyzed hydrogenation of beta-substituted (E)-beta-(acylamino)acrylic acids allows efficient enantioselective synthesis of beta-amino acids. The Z double bond isomers which possess an intramolecular hydrogen bond between amide and ester groups are more reactive but are hydrogenated with poor enantioselectivity. BINAP-Rh(I) complexes afford only moderate stereoselectivity with the opposite sense of enantioselection.

  DOI：

  10.1016/s0957-4166(00)86107-8

文献信息

• [EN] BICYCLIC PYRIMIDONE COMPOUNDS AS INHIBITORS OF LP-PLA2<br/>[FR] COMPOSÉS DE PYRIMIDONE BICYCLIQUES UTILISÉS EN TANT QU'INHIBITEURS DE LP-PLA2
  申请人：GLAXOSMITHKLINE IP DEV LTD

  公开号：WO2014114249A1

  公开（公告）日：2014-07-31

  The present invention relates to novel pyrimido[1,6-a]pyrimidin-6(2H)-one compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease.

  本发明涉及一种新型的抑制Lp-PLA2活性的嘧啶并[1,6-a]嘧啶-6(2H)-酮化合物，以及其制备方法、含有它们的组合物和它们在治疗与Lp-PLA2活性相关的疾病，例如动脉粥样硬化、阿尔茨海默病等方面的用途。
• BICYCLIC PYRIMIDONE COMPOUNDS AS INHIBITORS OF LP-PLA2
  申请人：GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED

  公开号：US20150344485A1

  公开（公告）日：2015-12-03

  The present invention relates to novel pyrimido[1,6-a]pyrimidin-6(2H)-one compounds that inhibit Lp-PLA 2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA 2 , for example atherosclerosis, Alzheimer's disease.

  本发明涉及一种新型的嘧啶[1,6-a]嘧啶-6(2H)-酮化合物，可抑制Lp-PLA2活性，其制备过程，包含它们的组合物以及它们在治疗与Lp-PLA2活性相关的疾病，例如动脉粥样硬化、阿尔茨海默病等方面的用途。
• Enantioselective synthesis of β-amino acids based on BINAP—ruthenium(II) catalyzed hydrogenation
  作者：William D. Lubell、Masato Kitamura、Ryoji Noyori

  DOI：10.1016/s0957-4166(00)86107-8

  日期：1991.1

  BINAP-Ru(II) catalyzed hydrogenation of beta-substituted (E)-beta-(acylamino)acrylic acids allows efficient enantioselective synthesis of beta-amino acids. The Z double bond isomers which possess an intramolecular hydrogen bond between amide and ester groups are more reactive but are hydrogenated with poor enantioselectivity. BINAP-Rh(I) complexes afford only moderate stereoselectivity with the opposite sense of enantioselection.